Merck & Co Inc (MRK)

Add to Watchlists
Create an Alert
Quickflows
89.57 +0.59  +0.66% NYSE Dec 12, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All MRK News

News

View All Events

Events

Date Type Description
01/31/2020 08:00 EST Misc Merck & Co Inc Fourth Quarter Earnings Conference Call in 2019
01/31/2020 Earnings Merck & Co Inc Fourth Quarter Earnings in 2019 Release
12/13/2019 Dividends Amount: 0.61, Declared Date: Nov 19 2019, Pay Date: Jan 08 2020
10/29/2019 08:00 EDT Misc Merck & Co Inc Third Quarter Earnings Conference Call in 2019
10/29/2019 Earnings Merck & Co Inc Third Quarter Earnings in 2019 Release
09/13/2019 Dividends Amount: 0.55, Declared Date: Jul 23 2019, Pay Date: Oct 07 2019
07/30/2019 08:00 EDT Misc Merck & Co Inc Second Quarter Earnings Conference Call in 2019
07/30/2019 Earnings Merck & Co Inc Second Quarter Earnings in 2019 Release
06/14/2019 Dividends Amount: 0.55, Declared Date: May 28 2019, Pay Date: Jul 08 2019
05/28/2019 09:00 EDT Misc Merck & Co Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 45.97B
Total Expenses (TTM) 33.64B
Net Income (TTM) 9.313B

Balance Sheet View Statement

Total Assets (Quarterly) 83.33B
Total Liabilities (Quarterly) 56.41B
Shareholders Equity (Quarterly) 26.84B

Cash Flow Statement View Statement

Cash from Operations (TTM) 12.24B
Cash from Investing (TTM) 312.00M
Cash from Financing (TTM) -12.42B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.merck.com
  • Investor Relations URL: http://investors.merck.com/investors/default.aspx
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Jan. 31, 2020
  • Last Earnings Release: Oct. 29, 2019
  • Next Ex-Dividend Date: Dec. 13, 2019
  • Last Ex-Dividend Date: Dec. 13, 2019
  • Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 89.57
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
XLV Health Care Select Sector SPDR® ETF 6.15%
RWMAX American Funds Washington Mutual R1 2.52%
RIDHX American Funds Income Fund of Amer R5E 2.18%
VTV Vanguard Value ETF 1.69%
VFINX Vanguard 500 Index Investor 0.88%
VOO Vanguard S&P 500 ETF 0.88%
VINIX Vanguard Institutional Index I 0.88%
FXAIX Fidelity® 500 Index 0.87%
SPY SPDR® S&P 500 ETF Trust 0.87%
IVV iShares Core S&P 500 ETF 0.87%
VSTSX Vanguard Total Stock Mkt Idx Instl Sel 0.73%
VTI Vanguard Total Stock Market ETF 0.73%

Comparables

Edit
ABT Abbott Laboratories
AMGN Amgen Inc
BIIB Biogen Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.